vs

Side-by-side financial comparison of Iveda Solutions, Inc. (IVDA) and Upstream Bio, Inc. (UPB). Click either name above to swap in a different company.

Upstream Bio, Inc. is the larger business by last-quarter revenue ($668.0K vs $626.0K, roughly 1.1× Iveda Solutions, Inc.). Iveda Solutions, Inc. runs the higher net margin — -258.6% vs -6356.1%, a 6097.5% gap on every dollar of revenue.

Iveda Solutions, Inc. is a technology provider specializing in cloud-based AI video surveillance, IoT-enabled smart sensing, and integrated smart city solutions. It serves public sector, enterprise, and education clients across North America and Asia, with core offerings covering remote security monitoring, smart facility management, and real-time data analysis tools for public safety use cases.

TCI Co., Ltd. is a Taiwanese contract development and manufacturing organization (CDMO) specialising in the research, development and production of functional beverages, dietary supplements and skincare products. Headquartered in the Neihu Technology Park in Taipei, TCI evolved from an original trading company founded in 1980 into a CDMO group serving clients across Asia, Europe and North America, and is publicly traded on Taiwan's over-the-counter market under the code 8436.

IVDA vs UPB — Head-to-Head

Bigger by revenue
UPB
UPB
1.1× larger
UPB
$668.0K
$626.0K
IVDA
Higher net margin
IVDA
IVDA
6097.5% more per $
IVDA
-258.6%
-6356.1%
UPB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IVDA
IVDA
UPB
UPB
Revenue
$626.0K
$668.0K
Net Profit
$-1.6M
$-42.5M
Gross Margin
3.6%
Operating Margin
-262.7%
-6911.2%
Net Margin
-258.6%
-6356.1%
Revenue YoY
-64.1%
Net Profit YoY
-7.1%
EPS (diluted)
$-0.33
$-0.78

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVDA
IVDA
UPB
UPB
Q4 25
$626.0K
$668.0K
Q3 25
$1.7M
$683.0K
Q2 25
$1.5M
$937.0K
Q1 25
$1.5M
$566.0K
Q4 24
$1.7M
Q3 24
$2.4M
$607.0K
Q2 24
$1.5M
Q1 24
$346.8K
Net Profit
IVDA
IVDA
UPB
UPB
Q4 25
$-1.6M
$-42.5M
Q3 25
$-221.3K
$-33.7M
Q2 25
$-564.2K
$-40.0M
Q1 25
$-793.7K
$-27.3M
Q4 24
$-1.5M
Q3 24
$-581.4K
$-16.0M
Q2 24
$-599.0K
Q1 24
$-1.3M
Gross Margin
IVDA
IVDA
UPB
UPB
Q4 25
3.6%
Q3 25
31.3%
Q2 25
29.1%
Q1 25
19.5%
Q4 24
11.9%
Q3 24
17.1%
Q2 24
32.7%
Q1 24
52.5%
Operating Margin
IVDA
IVDA
UPB
UPB
Q4 25
-262.7%
-6911.2%
Q3 25
-13.0%
-5539.4%
Q2 25
-34.8%
-4732.9%
Q1 25
-56.7%
-5656.0%
Q4 24
-87.3%
Q3 24
-25.4%
-3112.5%
Q2 24
-39.7%
Q1 24
-384.1%
Net Margin
IVDA
IVDA
UPB
UPB
Q4 25
-258.6%
-6356.1%
Q3 25
-13.4%
-4941.1%
Q2 25
-36.9%
-4265.3%
Q1 25
-53.8%
-4818.0%
Q4 24
-86.7%
Q3 24
-24.2%
-2634.6%
Q2 24
-39.0%
Q1 24
-371.9%
EPS (diluted)
IVDA
IVDA
UPB
UPB
Q4 25
$-0.33
$-0.78
Q3 25
$-0.07
$-0.63
Q2 25
$-0.20
$-0.74
Q1 25
$-0.28
$-0.51
Q4 24
$-0.60
Q3 24
$-0.27
$-6.96
Q2 24
$-0.30
Q1 24
$-0.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVDA
IVDA
UPB
UPB
Cash + ST InvestmentsLiquidity on hand
$5.2M
$341.5M
Total DebtLower is stronger
$393.4K
Stockholders' EquityBook value
$4.8M
$339.8M
Total Assets
$6.4M
$353.8M
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVDA
IVDA
UPB
UPB
Q4 25
$5.2M
$341.5M
Q3 25
$3.3M
$372.4M
Q2 25
$1.6M
$393.6M
Q1 25
$2.5M
$431.4M
Q4 24
$2.6M
Q3 24
$3.6M
$220.7M
Q2 24
$2.9M
Q1 24
$3.9M
Total Debt
IVDA
IVDA
UPB
UPB
Q4 25
$393.4K
Q3 25
$306.4K
Q2 25
$365.3K
Q1 25
$340.8K
Q4 24
$376.2K
Q3 24
$545.9K
Q2 24
$564.0K
Q1 24
$480.0K
Stockholders' Equity
IVDA
IVDA
UPB
UPB
Q4 25
$4.8M
$339.8M
Q3 25
$3.8M
$378.6M
Q2 25
$1.5M
$408.7M
Q1 25
$1.7M
$445.6M
Q4 24
$2.5M
Q3 24
$4.1M
$-160.3M
Q2 24
$2.8M
Q1 24
$3.3M
Total Assets
IVDA
IVDA
UPB
UPB
Q4 25
$6.4M
$353.8M
Q3 25
$5.8M
$391.2M
Q2 25
$4.4M
$420.5M
Q1 25
$4.5M
$456.2M
Q4 24
$5.2M
Q3 24
$9.1M
$232.7M
Q2 24
$6.8M
Q1 24
$6.6M
Debt / Equity
IVDA
IVDA
UPB
UPB
Q4 25
0.08×
Q3 25
0.08×
Q2 25
0.25×
Q1 25
0.20×
Q4 24
0.15×
Q3 24
0.13×
Q2 24
0.20×
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVDA
IVDA
UPB
UPB
Operating Cash FlowLast quarter
$-252.4K
$-30.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVDA
IVDA
UPB
UPB
Q4 25
$-252.4K
$-30.6M
Q3 25
$-317.0K
$-22.2M
Q2 25
$-1.3M
$-39.2M
Q1 25
$-126.0K
$-41.2M
Q4 24
$-889.8K
Q3 24
$-1.2M
Q2 24
$-999.7K
Q1 24
$-1.3M
Free Cash Flow
IVDA
IVDA
UPB
UPB
Q4 25
Q3 25
$-22.3M
Q2 25
Q1 25
Q4 24
$-889.8K
Q3 24
$-1.5M
Q2 24
$-1.1M
Q1 24
$-1.5M
FCF Margin
IVDA
IVDA
UPB
UPB
Q4 25
Q3 25
-3265.6%
Q2 25
Q1 25
Q4 24
-51.1%
Q3 24
-64.1%
Q2 24
-72.6%
Q1 24
-427.3%
Capex Intensity
IVDA
IVDA
UPB
UPB
Q4 25
Q3 25
9.4%
Q2 25
Q1 25
Q4 24
0.0%
Q3 24
12.5%
Q2 24
7.5%
Q1 24
54.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons